Ertugliflozin 15mg Tablets

Ertugliflozin Tablets 15 mg
  • Dosage: Ertugliflozin 15 mg
  • Packaging: 10tablets/blister*10/box
  • Shelf Life: 36months 

Click to add this item to cart.

Product Description

Product NameErtugliflozin Tablets (Ertugliflozin 15mg Oral Tablets)
SpecificationEach tablet contains: Ertugliflozin 15mg
Dosage FormOral Film-Coated Tablet (for oral administration)
Active IngredientErtugliflozin
Pharmacological ClassSodium-Glucose Cotransporter 2 (SGLT2) Inhibitor (Antidiabetic Agent)
Route of AdministrationOral administration (swallowed whole with water; take at approximately the same time each morning, with or without food).
PackagingBlister pack (PVC-Alu) or HDPE bottle, typically 30 tablets per blister pack or bottle
StorageStore below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze.
Shelf Life36 months (unopened)

Product Overview

Ertugliflozin Tablets is an oral preparation containing Ertugliflozin 15mg per film-coated tablet. Ertugliflozin is a selective sodium-glucose cotransporter 2 (SGLT2) inhibitor used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. SGLT2 inhibitors work by a mechanism that is independent of insulin secretion, which differentiates them from other classes of antidiabetic medications. The product is formulated as film-coated tablets for convenient once-daily oral dosing.

Ertugliflozin 15mg Tablets: What the Published Guidance Says

Human and analogue insulins alongside the oral hypoglycaemics and cardiorenal-metabolic agents added to the WHO Model List in its September 2025 revision.

Before Ertugliflozin 15mg Tablets is quoted, we confirm the monograph, the strength on the artwork and the release testing required by your market — the points summarised here.

Each point above is reproduced because it has a practical consequence for Ertugliflozin 15mg Tablets: the strength you can register, the pack you can release, or the wording permitted on the label. Your national prescribing information always takes precedence.

Ertugliflozin 15mg Tablets — Supply Parameters

Product NameErtugliflozin Tablets (Ertugliflozin 15mg Oral Tablets)
SpecificationEach tablet contains: Ertugliflozin 15mg
Dosage FormOral Film-Coated Tablet (for oral administration)
Active IngredientErtugliflozin
Pharmacological ClassSodium-Glucose Cotransporter 2 (SGLT2) Inhibitor (Antidiabetic Agent)
Route of AdministrationOral administration (swallowed whole with water; take at approximately the same time each morning, with or without food).
StorageStore below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze.
Therapeutic groupDiabetes & Insulin — Diabetes & Insulin
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Dapagliflozin 10mg Tablets, Canagliflozin 300mg Tablets, Empagliflozin 25mg Tablets, Finerenone 20mg Tablets, Repaglinide Tablets 2mg, Sotagliflozin 400mg Tablets, Mixed Protamine Human Insulin 30R, Insulin Glargine Injection 100IU/mL 3ml Cartridge.

Quality Control, Pharmacopoeial Standards & Documentation

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Release testing for Ertugliflozin 15mg Tablets follows the monograph you nominate — USP, EP, BP or CP. If the presentation is not covered by a monograph, the specification is frozen in writing with your quality team before the batch is manufactured.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

A typical release panel for this presentation covers:

  • Testing for uniformity of dosage units
  • Testing for water content and pH where applicable
  • Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
  • Testing for microbial limits and preservative efficacy (multi-dose presentations)
  • Testing for heavy metals and elemental impurities
  • Testing for packaging integrity and seal testing

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Packaging, Labelling & Export

  • Pack size: Blister pack (PVC-Alu) or HDPE bottle, typically 30 tablets per blister pack or bottle. Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze..
  • Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
  • Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
  • Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Registration, Dossier & Tender Support

The legal manufacturer named on every document for Ertugliflozin 15mg Tablets is Sinophare Bio-technology Co., Ltd., DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. The same entity appears on the GMP certificate and on the dossier submitted to your regulator.

  • Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
  • Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
  • Batch manufacturing and packaging records released for inspection on request during supplier audits.
  • Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
  • CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.

Ertugliflozin 15mg Tablets is presented here against medicines for diabetes listed in the WHO Model List. Inclusion in an essential-medicines list does not authorise sale in any particular country — the marketing authorisation for that market is a separate step.

Frequently Asked Questions

What pack size is available for Ertugliflozin 15mg Tablets?

Standard commercial packaging for this line is Blister pack (PVC-Alu) or HDPE bottle, typically 30 tablets per blister pack or bottle. Alternative pack sizes are produced to your specification and are supported by the corresponding stability data.

What documentation comes with a shipment of Ertugliflozin 15mg Tablets?

The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 36 months.

Does the batch documentation for Ertugliflozin 15mg Tablets support a registration filing?

The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

Do you supply human insulin as well as analogues?

Yes. We supply human short-acting, isophane and premixed 30/70 protamine human insulin, and insulin glargine. The Model List notes that quality-assured biosimilars are included in its analogue listings.

Which SGLT2 inhibitors do you supply?

Empagliflozin, dapagliflozin, canagliflozin and ertugliflozin in tablet form. Empagliflozin is the molecule specifically listed in section 18.5.2 of the Model List, with canagliflozin and dapagliflozin named as therapeutic equivalents.

Related Diabetes & Insulin Products

Browse the full Diabetes & Insulin range; all Tablets; the complete product catalogue.

Request a Quotation for Ertugliflozin 15mg Tablets

Tell us the monograph, pack size and quantity required for Ertugliflozin 15mg Tablets 15mg, together with the destination market, and the quotation will state lead time and the documents that ship with the batch. Samples for registration can be added to the same order.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products